UK's first MRI-led freezing procedure for prostate cancer

Clinicians at University Hospital Southampton NHS Foundation Trust will be the first in the UK to treat prostate cancer using frozen needles guided by magnetic resonance imaging (MRI).

MRI-guided cryotherapy will be performed by urologists and radiologists at Southampton General Hospital, and involves placing hollow needles into the prostate and passing through compressed argon gases which cool rapidly to around minus 40°C to freeze and destroy cancer cells in the affected part of the gland.

Using MRI, clinicians are able to watch ice develop on the needles in 3D and in real-time, providing much more detail and enabling more accuracy when destroying tumours through the ability to 'sculpt' balls of ice to cover the affected area. The majority of patients who undergo the treatment return home the same day.

Tim Dudderidge, a consultant urological surgeon at the trust, said: “This is a fantastic development in how we deliver cryotherapy for patients with prostate cancer. The tumour is much more visible on MRI and we can place needles to get optimum ice coverage into the most aggressive part of the tumour.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho